Literature DB >> 16122732

Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma.

Giovanna E Carpagnano1, Maria P Foschino Barbaro, Onofrio Resta, Enzo Gramiccioni, Nicola V Valerio, Paolo Bracciale, Giuseppe Valerio.   

Abstract

The measure of inflammatory cytokines in the exhaled breath condensate has been recently proposed for use in monitoring asthma and the therapeutic response to steroids. The aim of the present study was to investigate the usefulness of measuring exhaled IL-6, IL-4 and pH in mild persistent asthma. Furthermore the effects on these markers of inhaled steroids were assessed. The study enrolled 28 asthmatic (15 males, 38+/-12 years) and 15 healthy subjects (5 males, 35+/-6 years). IL-6, IL-4 and pH were measured in the exhaled breath condensate of the subjects studied. Significantly higher concentrations of IL-6 and IL-4 were observed in the breath condensate of asthmatic patients (7.1+/-1.1 and 64.4+/-8.3 pg/ml) compared to controls (2.7+/-0.6 and 31.7+/-3.5 pg/ml), p<0.001. Furthermore, exhaled IL-4 fell significantly after treatment with inhaled steroids for 6 months (47.9+/-3.2 pg/ml, p<0.001) while exhaled IL-6 did not (6.4+/-1.0 pg/ml, p=0.8). The exhaled pH turned out to be lower in asthmatic subjects than in controls (7.39+/-0.11 vs. 7.85+/-0.14; P<0.001) but trended towards control levels after steroid treatment (7.65+/-0.16, P<0.001). We conclude that the measurement of exhaled IL-4 and pH in mild asthmatic subjects could be a useful way of monitoring their airway inflammation as well as their response to the treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122732     DOI: 10.1016/j.ejphar.2005.06.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

Review 2.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

3.  Aluminum gallium nitride (GaN)/GaN high electron mobility transistor-based sensors for glucose detection in exhaled breath condensate.

Authors:  Byung Hwan Chu; Byoung Sam Kang; Sheng Chun Hung; Ke Hung Chen; Fan Ren; Andrew Sciullo; Brent P Gila; Stephen J Pearton
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

Review 4.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

Review 5.  Inflammatory Biomarkers in Exhaled Breath Condensate: A Systematic Review.

Authors:  Federica Ghelli; Marco Panizzolo; Giacomo Garzaro; Giulia Squillacioti; Valeria Bellisario; Nicoletta Colombi; Enrico Bergamaschi; Irina Guseva Canu; Roberto Bono
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

6.  Symptoms, but not a biomarker response to inhaled corticosteroids, predict asthma in preschool children with recurrent wheeze.

Authors:  E M M Klaassen; K D G van de Kant; Q Jöbsis; S T P Høvig; C P van Schayck; G T Rijkers; E Dompeling
Journal:  Mediators Inflamm       Date:  2012-12-05       Impact factor: 4.711

7.  Breath acidification in adolescent runners exposed to atmospheric pollution: a prospective, repeated measures observational study.

Authors:  Jill M Ferdinands; Carol A Gotway Crawford; Roby Greenwald; David Van Sickle; Eric Hunter; W Gerald Teague
Journal:  Environ Health       Date:  2008-03-07       Impact factor: 5.984

Review 8.  Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.

Authors:  Dean H Conrad; Jesse Goyette; Paul S Thomas
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

9.  Effect of Inhaled Budesonide on Interleukin-4 and Interleukin-6 in Exhaled Breath Condensate of Asthmatic Patients.

Authors:  Chun-Hua Chi; Ji-Ping Liao; Yan-Ni Zhao; Xue-Ying Li; Guang-Fa Wang
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.